Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Recruiting
N/A
Interventional Study
Parkinson's Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 120 (estimated)
- Sponsor
- University Hospital, Lille · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult men and women with all stages of PD
* Without severe chronic neurological or mental or psychiatric pathology
* Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
* able to come (alone or accompanied) to consultation
* Affiliate o…
Contacts